400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Others / Others-Others / Naxitamab
CAS No.: 1879925-92-4
Synonyms: Naxitamab-gqgk;Humanized 3F8;Hu3F8
Naxitamab is a humanised (IgG1) anti-GD2 (hu3F8) monoclonal antibody was developed by the Memorial Sloan Kettering Cancer Center (with commercial rights licenced to Y-mAbs therapeutics Inc.) for the treatment of neuroblastoma, osteosarcoma and other GD2-positive cancers.
实验方案
技术信息
CAS号 | 1879925-92-4 | 储存条件 |
|
|
分子式 | 运输 | 蓝冰 | ||
分子量 | N/A | 别名 | Naxitamab-gqgk;Humanized 3F8;Hu3F8 |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网